Picture of MannKind logo

MNKD MannKind News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapSucker Stock

MannKind Corp reports results for the quarter ended in September 30 - Earnings Summary

* MannKind Corp  MNKD.OQ  reported quarterly adjusted
earnings of
5 cents​​ per share for the quarter ended September 30, higher
than the same quarter last year, when the company reported EPS
of 1 cents.  The mean expectation of four analysts for the
quarter was for earnings of 3 cents per share. Wall Street
expected results to range from 2 cents to 4 cents per share.
    * Revenue fell 61.5% to $19.73 million from a year ago;
analysts
expected $74.50 million. 
    * MannKind Corp's reported EPS for the quarter was 4 cents​.
    * The company reported quarterly net income of $11.55
million.
    * MannKind Corp shares had risen by 17.5% this quarter and
gained 103.0% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 20% in
the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for MannKind Corp is
$9.00 
This summary was machine generated from LSEG data November 8 at
05:24 a.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2024      0.03           0.05           Beat
 Jun. 30 2024      0.01           -0.01          Missed
 Mar. 31 2024      0.03           0.04           Beat
 Dec. 31 2023      0.00           0.00           Met

Recent news on MannKind

See all news